News & Updates

Histologic inflammation of IBD a risk factor for serious infections
Histologic inflammation of IBD a risk factor for serious infections
03 Nov 2023

Among individuals with inflammatory bowel disease (IBD), histologic inflammation appears to contribute to an increased risk of serious infections such as sepsis, according to a study, suggesting that achieving remission may reduce infections in IBD.

Histologic inflammation of IBD a risk factor for serious infections
03 Nov 2023
Biomarker-driven therapies superior to standard care in breast cancer
Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023

Patients with breast cancer may gain greater therapeutic advantages from biomarker-driven than standard-of-care therapies, suggests a study.

Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023
Esketamine outperforms quetiapine in head-to-head depression trial
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023 byJairia Dela Cruz

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023